Package 72162-1526-3

Brand: bupropion hydrochloride (xl)

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 72162-1526-3
Digits Only 7216215263
Product NDC 72162-1526
Description

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72162-1526-3)

Marketing

Marketing Status
Marketed Since 2023-12-07
Brand bupropion hydrochloride (xl)
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "bdb479e5-716d-42c3-9b39-7ca6c5351cca", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["cefaaa17-f79a-4ba6-8f97-a59f60e07b75"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72162-1526-3)", "package_ndc": "72162-1526-3", "marketing_start_date": "20231207"}, {"sample": false, "description": "500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72162-1526-5)", "package_ndc": "72162-1526-5", "marketing_start_date": "20231207"}], "brand_name": "Bupropion Hydrochloride (XL)", "product_id": "72162-1526_bdb479e5-716d-42c3-9b39-7ca6c5351cca", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "72162-1526", "generic_name": "bupropion hydrochloride", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "(XL)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA207479", "marketing_category": "ANDA", "marketing_start_date": "20170412", "listing_expiration_date": "20261231"}